The global pharmaceutical industry experienced a 49% drop in company filings mentions of virtual care in Q2 2023 compared with the previous quarter, with the highest share accounted for by ICON with 100% year-on-year increase, according to GlobalData’s analysis of over 56 pharmaceutical company filings. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on market segments forecast up to 2030. Buy the report here.
Notably, virtual care was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of connectivity and cloud, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, ICON had the greatest increase in references for virtual care in Q2 2023, compared with the previous quarter. GlobalData identified six virtual care-related sentences in the company's filings - 0.6% of all sentences - and an increase of 100% in Q2 2023 compared with Q2 2022. Biogen’s mentions of virtual care rose by 100% to 1.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for virtual care in Q2 2023 was 76.
For further understanding of GlobalData's Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.